Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

LMO3

Introduction

LIM domain only protein 3 is a transcription co-factor, which in humans is encoded by the LMO3 gene.[1][2][3] LMO3 interacts with the tumor suppressor p53 and regulates its function.[4] LMO3 is considered to be an oncogene in Neuroblastoma.[5]

References

References

  1. ↑ Larsen S, Yokochi T, Isogai E, Nakamura Y, Ozaki T, Nakagawara A (February 2010). “LMO3 interacts with p53 and inhibits its transcriptional activity”. Biochemical and Biophysical Research Communications. 392 (3): 252–7. doi:10.1016/j.bbrc.2009.12.010. PMID 19995558.
  2. ↑ Shi J, Cai W, Chen X, Ying K, Zhang K, Xie Y (August 2001). “Identification of dopamine responsive mRNAs in glial cells by suppression subtractive hybridization”. Brain Research. 910 (1–2): 29–37. doi:10.1016/S0006-8993(01)02393-9. PMID 11489251.
  3. ↑ EntrezGene 55885
  4. ↑ Larsen S, Yokochi T, Isogai E, Nakamura Y, Ozaki T, Nakagawara A (February 2010). “LMO3 interacts with p53 and inhibits its transcriptional activity”. Biochemical and Biophysical Research Communications. 392 (3): 252–7. doi:10.1016/j.bbrc.2009.12.010. PMID 19995558.
  5. ↑ Larsen S, Yokochi T, Isogai E, Nakamura Y, Ozaki T, Nakagawara A (February 2010). “LMO3 interacts with p53 and inhibits its transcriptional activity”. Biochemical and Biophysical Research Communications. 392 (3): 252–7. doi:10.1016/j.bbrc.2009.12.010. PMID 19995558.
Further reading

Further reading

  • Friedel S, Saar K, Sauer S, Dempfle A, Walitza S, Renner T, Romanos M, Freitag C, et al. (October 2007). “Association and linkage of allelic variants of the dopamine transporter gene in ADHD”. Molecular Psychiatry. 12 (10): 923–33. doi:10.1038/sj.mp.4001986. PMID 17579611.
  • Davis C, Levitan RD, Kaplan AS, Carter J, Reid C, Curtis C, Patte K, Kennedy JL (October 2007). “Dopamine transporter gene (DAT1) associated with appetite suppression to methylphenidate in a case-control study of binge eating disorder”. Neuropsychopharmacology. 32 (10): 2199–206. doi:10.1038/sj.npp.1301348. PMID 17314918.
  • Lim J, Hao T, Shaw C, Patel AJ, Szabó G, Rual JF, Fisk CJ, Li N, et al. (May 2006). “A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration”. Cell. 125 (4): 801–14. doi:10.1016/j.cell.2006.03.032. PMID 16713569.
  • Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, et al. (October 2005). “Towards a proteome-scale map of the human protein-protein interaction network”. Nature. 437 (7062): 1173–8. doi:10.1038/nature04209. PMID 16189514.
  • Aoyama M, Ozaki T, Inuzuka H, Tomotsune D, Hirato J, Okamoto Y, Tokita H, Ohira M, et al. (June 2005). “LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma”. Cancer Research. 65 (11): 4587–97. doi:10.1158/0008-5472.CAN-04-4630. PMID 15930276.
  • Foroni L, Boehm T, White L, Forster A, Sherrington P, Liao XB, Brannan CI, Jenkins NA, et al. (August 1992). “The rhombotin gene family encode related LIM-domain proteins whose differing expression suggests multiple roles in mouse development”. Journal of Molecular Biology. 226 (3): 747–61. doi:10.1016/0022-2836(92)90630-3. PMID 1507224.